• Share
  • Email
  • Print

Oded Green

Partner
+1.412.355.6584
Fax +1.412.355.6501
Oded Green focuses his practice on a wide range of corporate and transactional matters related to mergers and acquisitions (local and international), venture capital investments, joint ventures, debt and equity financing, corporate governance and general corporate law. In addition, Mr. Green serves clients in a broad array of commercial needs, including licensing, supply, distribution and operating arrangements.

Mr. Green’s clients include companies in a diverse range of industries, including information technology, biotechnology, manufacturing, chemicals, steel and other traditional industries. Prior to joining K&L Gates, Mr. Green practiced corporate law in Israel, and gained substantial experience in cross border related transactions. Mr. Green is fluent in Hebrew.

Professional/Civic Activities

  • Pennsylvania Bar Association
  • New York State Bar Association
  • American Bar Association
  • Israeli Bar Association
Mergers and Acquisitions; Strategic Acquisitions
  • Represented a Singapore based public company on its cross-border acquisition of a developer of autonomous mobile robots for manufacturing environments, hospitals and other commercial settings.
  • Represented a medical device company in its sale to a British public pharmaceutical company ($250 million).
  • Represented a chemicals company in the divestiture of one of its line of products.
  • Represented a publicly-held company in its acquisition of a metal forging facility and a related bank financing.
  • Represented a subsidiary of a leading academic institution in connection with the sale of its portfolio of technology companies.
  • Represented a drug discovery company in connection with an equity investment and a related license agreement with a public pharmaceutical company ($345 million).
  • Represented a lumber and building materials retailer in its acquisition of a building materials company.
  • Represented a producer of decorative fabrics in its sale to a global provider of performance fabrics.
  • Represented a supplier of petroleum products in its sale to a fuel distribution company.
  • Represented a distributor of industrial wood products and accessories to a wholesale distributor of building construction materials.
  • Represented an online auction company in connection with its sale to a private equity fund.
  • Represented a credit card processing company in a series of acquisitions of portfolio companies.
  • Represented a healthcare software solution company in connection with the sale of its business.
  • Represented a construction software company in connection with the sale of its shares.
  • Represented a chain of supply consulting company in connection with its sale.
  • Represented a developer of lane departure warning systems in connection with the sale of its business to a publicly-held company.  
Venture Capital Investments; Private Offerings
  • Represented a drug discovery company in connection with various rounds of equity raise (over $60 million) and convertible debt raise (over $26 million).
  • Represented a technology company in the railroad industry in connection with several rounds of private offerings, and a related joint venture arrangement with a public railroad company.
  • Represented a fund specializing in incubation, seed, and early stage investments in life sciences companies in connection with its investments and management of a portfolio of companies.
  • Represented a high-tech baby gear company in connection with two venture capital investments in the aggregate amount of $60 million.
  • Represented a developer of a personal air quality monitor in a strategic investment by a U.S. company, and a related Joint Development Agreement.
  • Represented a developer of a personal air quality monitor in a strategic investment by an Indian company.
  • Represented a developer of a drug for the treatment of colon cancer (located in China and the U.S.) in its negotiations with a leading pharmaceutical company for an investment and a related option to acquire the Company (over $100 million).
  • Represented a venture capital firm focusing on ophthalmology in connection with its investment in an Israeli company (Series B round).
  • Represented an academic institution in connection with its structuring of an early stage accelerator for life sciences companies.
  • Represented a public benefit corporation in connection with a venture capital investment.
Commercial Contracts
  • Represented a high-tech baby gear company in connection with the license of its technology to a global toy manufacturer ($215 million).
  • Represented a technology company in the rail industry in connection with a strategic investment and a related services agreement with a leading railroad company.
  • Advised a global company in connection with its contract lifecycle management (distribution, sales, and supply).
  • Represented a bio-simulation company, in connection with a strategic investment and a joint development agreement with a global healthcare public company.
  • Represented a developer of hospital inventory management systems using RFID technology in connection with its commercialization agreement with a global pharmaceutical company.
  • Represented a Japanese technology company in connection with a long term supply of batteries for industrial use.
  • Represented technology companies, including software, medical device and life science companies, in connection with their spin-offs and licensing arrangements with academic institutions.
Israeli Related Matters
  •  Practiced law in Israel; represented foreign companies entering the Israeli market.
  • Represented a U.S. based investor in connection with its investment in an Israeli medical device company, and its subsequent reincorporation in the U.S.
  • Represented a U.S. based advertising company in connection with its strategic investment in an Israeli online market research company.
  • Represented a U.S. company in connection with its on-going relationship with the Israeli Railroad Company.
  • Represented an Israeli technology company in connection with the listing of its securities on London’s AIM.